Medicine
Lacosamide 50 mg tablet
Lacosamide 50 mg tablet is a generic prescription medicine for oral use, made by 27 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to…
Key facts
- Active ingredient (INN)
- Lacosamide
- Brand
- Sold under the generic name
- Strength
- 50 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 30 tablets, 60 tablets and 64 more
- Manufacturers
- Alembic PharmaceuticalsIndiaAscend LaboratoriesIndiaCamber PharmaceuticalsIndiaGlenmark PharmaceuticalsIndiaSun Pharmaceutical IndustriesIndiaAurobindo PharmaIndiaMacleods PharmaceuticalsIndiaMSN LaboratoriesIndiaUnichem LaboratoriesIndiaIndoco RemediesIndia27 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Schedule CV
- ATC code
- N03AX18 Lacosamide
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 17 March 2022
- Identifiers
- RxCUI 809987, 809992, 809996 +1DailyMed set ID f047077c-2ac7-30d0-e053-2995a90ae429, 0e21389b-2f51-4975-aa21-fc5c9dd9f6dc, e3658b3c-f193-41a2-acc7-0bb912e27173 +26NDC 51407-721, 53746-923, 70518-4503 +26Application ANDA204921, ANDA204857, ANDA204974 +10
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 27 labelers. The register lists 67 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet, film coated in 1 carton | 46708-171-10 | Alembic PharmaceuticalsIndia | 18 March 2022 |
| 30 tablet, film coated in 1 bottle | 46708-171-30 | Alembic PharmaceuticalsIndia | 18 March 2022 |
| 60 tablet, film coated in 1 bottle | 46708-171-60 | Alembic PharmaceuticalsIndia | 18 March 2022 |
| 1000 tablet, film coated in 1 bottle | 46708-171-91 | Alembic PharmaceuticalsIndia | 18 March 2022 |
| 100 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 62332-171-10 | Alembic PharmaceuticalsIndia | 18 March 2022 |
| 30 tablet, film coated in 1 bottle | 62332-171-30 | Alembic PharmaceuticalsIndia | 18 March 2022 |
| 60 tablet, film coated in 1 bottle | 62332-171-60 | Alembic PharmaceuticalsIndia | 18 March 2022 |
| 1000 tablet, film coated in 1 bottle | 62332-171-91 | Alembic PharmaceuticalsIndia | 18 March 2022 |
| 500 tablet, film coated in 1 bottle | 67877-733-05 | Ascend LaboratoriesIndia | 1 April 2022 |
| 6 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 67877-733-31 | Ascend LaboratoriesIndia | 1 April 2022 |
| 60 tablet, film coated in 1 bottle | 67877-733-60 | Ascend LaboratoriesIndia | 1 April 2022 |
| 90 tablet, film coated in 1 bottle | 67877-733-90 | Ascend LaboratoriesIndia | 1 April 2022 |
| 3 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 65862-747-03 | Aurobindo PharmaIndia | 5 January 2023 |
| 60 tablet, film coated in 1 bottle | 65862-747-60 | Aurobindo PharmaIndia | 5 January 2023 |
| 500 tablet, film coated in 1 bottle | 31722-812-05 | Camber PharmaceuticalsIndia | 17 March 2022 |
| 180 tablet, film coated in 1 bottle | 31722-812-18 | Camber PharmaceuticalsIndia | 17 March 2022 |
| 100 tablet, film coated in 1 blister pack | 31722-812-32 | Camber PharmaceuticalsIndia | 17 March 2022 |
| 60 tablet, film coated in 1 bottle | 31722-812-60 | Camber PharmaceuticalsIndia | 17 March 2022 |
| 1000 tablet, film coated in 1 bottle | 68462-678-10 | Glenmark PharmaceuticalsIndia | 18 March 2022 |
| 30 tablet, film coated in 1 bottle | 68462-678-30 | Glenmark PharmaceuticalsIndia | 18 March 2022 |
| 60 tablet, film coated in 1 bottle | 68462-678-60 | Glenmark PharmaceuticalsIndia | 18 March 2022 |
| 60 tablet in 1 bottle | 14445-129-60 | Indoco RemediesIndia | 20 March 2022 |
| 60 tablet, film coated in 1 bottle | 33342-302-09 | Macleods PharmaceuticalsIndia | 24 May 2024 |
| 100 tablet, film coated in 1 bottle | 33342-302-11 | Macleods PharmaceuticalsIndia | 24 May 2024 |
| 500 tablet, film coated in 1 bottle | 69539-025-05 | MSN LaboratoriesIndia | 19 March 2022 |
| 60 tablet, film coated in 1 bottle | 69539-025-60 | MSN LaboratoriesIndia | 19 March 2022 |
| 1000 tablet, film coated in 1 bottle | 47335-918-18 | Sun Pharmaceutical IndustriesIndia | 19 March 2022 |
| 180 tablet, film coated in 1 bottle | 47335-918-82 | Sun Pharmaceutical IndustriesIndia | 19 March 2022 |
| 60 tablet, film coated in 1 bottle | 47335-918-86 | Sun Pharmaceutical IndustriesIndia | 19 March 2022 |
| 500 tablet, film coated in 1 bottle | 29300-364-05 | Unichem LaboratoriesIndia | 1 December 2024 |
| 60 tablet, film coated in 1 bottle | 29300-364-16 | Unichem LaboratoriesIndia | 1 December 2024 |
| 500 tablet in 1 bottle | 53746-923-05 | Amneal Pharmaceuticals of New York | 17 May 2023 |
| 60 tablet in 1 bottle | 53746-923-60 | Amneal Pharmaceuticals of New York | 17 May 2023 |
| 500 tablet, film coated in 1 bottle | 51991-348-05 | Breckenridge Pharmaceutical | 18 March 2022 |
| 60 tablet, film coated in 1 bottle | 51991-348-06 | Breckenridge Pharmaceutical | 18 March 2022 |
| 60 tablet in 1 bottle | 71921-220-06 | Florida Pharmaceutical Products | 21 September 2023 |
| 6 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 85742-008-07 | Kanchan Healthcare | 6 October 2025 |
| 60 tablet, film coated in 1 bottle, plastic | 85742-008-08 | Kanchan Healthcare | 23 October 2025 |
| 1000 tablet, film coated in 1 bottle | 50228-192-10 | ScieGen Pharmaceuticals | 18 March 2022 |
| 30 tablet, film coated in 1 bottle | 50228-192-30 | ScieGen Pharmaceuticals | 18 March 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Lacosamide 50 mg tablet.
Other strengths and forms of Lacosamide
Clinical summary
Lacosamide is a prescription medicine indicated for treatment of partial-onset seizures in patients 1 month of age and older, among other approved uses. It is available as tablets, oral solution and injection for intravenous use. MedsAcross supplies Lacosamide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about LacosamideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Vimpat prescribing information (UCB) · U.S. National Library of Medicine, DailyMed
- Lacosamide UCB: European public assessment report (EPAR) · European Medicines Agency
- Vimpat: European public assessment report (EPAR) · European Medicines Agency
Need Lacosamide 50 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.